Monday, 26 September 2016
NovaBay Pharmaceuticals Inc.
|AMEX : NBY|
23 Sep 16 00:00
NovaBay Pharmaceuticals, Inc, formerly NovaCal Pharmaceuticals, Inc, is a biopharmaceutical company, which develops products for the eye care market. more»
01:52 | 20/9/16
NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) announces that data from a Phase 2b clinical study with Auriclosene Irrigating Solution (AIS) demonstrated statistically significant and clinically meaningful results in the prevention of urinary catheter ... more»
Infoblox Inc (NYSE: BLOX) shares rose 15 percent to $26.25 in pre-market trading as the company announced its acquisition by Vista Equity Partners for $26.50 per share in cash. more»
22:41 | 12/9/16
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® lid and lash hygiene in the domestic eye care market, announces that its ... more»
01:18 | 10/9/16
AT&T, Inc. (NYSE:T) traded 13.52 Million shares on last trading day with closing price of $41.19. Company gross margin stands at 54.20% whereas its return on investment (ROI) is 7.10%. more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW